OTC · Financial Statements
Abattis Bioceuticals Corp. (ATTBF) Financial Statements
$0.00
OTC: ATTBF
Market Cap $14334
Overview Financials Dividend Abattis Bioceuticals Corp. most recently reported annual revenue of $0, net profit of $-3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2015 2016 2017 2018 2019 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-2.0M $-6.0M $-17.0M $-4.0M Net Profit $-4.0M $-2.0M $-8.0M $-78.0M $-3.0M EPS $-0.06 $-0.02 $-0.05 $-0.24 $-0.01 Op Margin -3347.6% — — -207542.2% -1108.7%
Balance Sheet (USD)
Metric 2015 2016 2017 2018 2019 Total Assets $2.0M $1.0M $1.0M $11.0M $19.0M Total Liabilities $1.0M $1.0M $0 $0 $9.0M Cash $0 $0 $1.0M $4.0M $2.0M Borrowings $0 $0 $0 $0 $2.0M
Cash Flow (USD)
Metric 2015 2016 2017 2018 2019 Operating Cash Flow $-2.0M $-1.0M $-1.0M $-8.0M $9.0M Investing Cash Flow $1.0M $0 $-1.0M $-16.0M $-17.0M Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $0 $0 $0 $4.0M $-2.0M Free Cash Flow $-2.0M $-1.0M $-2.0M $-9.0M $4.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.15 FCF Yield 21772.55% Quick Ratio 0.68 Interest Coverage -80.16 Return 1Y 200.00% Return 3Y 200.00% Return 5Y —
Screens featuring this stock